AU Patent

AU2001266690A1 — Process for the synthesis of (2r, 2-alpha-r)-4-benzyl-2-(1-(3,5-bis(trifluoromethyl)phenyl) ethoxy)-1,4-oxazin-3-one

Assigned to Merck and Co Inc · Expires 2001-12-17 · 24y expired

What this patent protects

Patent listed against Emend.

Drugs covered by this patent

Patent Metadata

Patent number
AU2001266690A1
Jurisdiction
AU
Classification
—
Expires
2001-12-17
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.